Export 2629 results:
First reported case of transfusion-transmitted Ross River virus infection. The Medical journal of Australia// Med J Aust. 2015;202(5):267-70.
The health implications of low hemoglobin deferral in infrequent blood donors. //Transfusion. 2015;55(1):86-90.
Healthy Babies after Intrauterine Transfer of Mosaic Aneuploid Blastocysts. The New England journal of medicine//N Engl J Med. 2015;373(21):2089-90.
Hemolysis in patients with antibody deficiencies on immunoglobulin replacement treatment. Transfusion. 2015;55:6.
A hemolytic anti-LKE associated with a rare LKE-negative, "weak P" red blood cell phenotype: alloanti-LKE and alloanti-P recognize galactosylgloboside and monosialogalactosylgloboside (LKE) antigens. Transfusion//Transfusion. 2015;55(1):115-28.
A hemolytic anti-LKE associated with a rare LKE-negative, "weak P" red blood cell phenotype: alloanti-LKE and alloanti-P recognize galactosylgloboside and monosialogalactosylgloboside (LKE) antigens. //Transfusion. 2015;55(1):115-128.
Hemolytic events after the administration of lyophilized versus liquid immune globulin: an analysis of a single manufacturer’s safety database. Transfusion. 2015;55:7.
Human T lymphotropic virus type-1-associated myelopathy manifesting shortly after living-donor renal transplantation. Internal medicine (Tokyo, Japan)// Intern Med. 2015;54(1):75-8.
Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab. Transfusion//Transfusion. 2015;55(3):623-8.
Hyperhemolysis syndrome in patients with sickle cell anemia: report of three cases. Transfusion//Transfusion. 2015;55(6 Pt 2):1394-8.
Hypotensive transfusion reactions in the era of prestorage leukoreduction. Transfusion//Transfusion. 2015;55(7):1668-74.
The Impact of Donor Viral Replication at Transplant on Recipient Infections Posttransplant: A Prospective Study. //Transplantation. 2015;99(3):602-608.
Incidence and natural history of intravenous immunoglobulin-induced aseptic meningitis: a retrospective review at a single tertiary care center. Transfusion//Transfusion. 2015;55(11):2597-605.
Incidence, risk factors, and outcome of transfusion-related acute lung injury in critically ill children: A retrospective study. //J Crit Care. 2015;30(1):55-59.
Increased risk of volume overload with plasma compared with four-factor prothrombin complex concentrate for urgent vitamin K antagonist reversal. Transfusion. 2015;55(11):2722-9.
Infectivity of blood components from donors with occult hepatitis B infection - results from an Australian lookback programme. Vox sanguinis// // Vox Sang. 2015;108(2):113-22.
An inventory of concerns behind blood safety policies in five Western countries. Transfusion. 2015;55(12):16.
Keeping Blood Transfusion Safe From West Nile Virus: American Red Cross Experience, 2003 to 2012. Transfus Med Rev. 2015;29(3):53.
Laboratory identification of donor-derived coxsackievirus b3 transmission. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons// // Am J Transplant. 2015;15(2):555-9.
Laboratory Identification of Donor-Derived Coxsackievirus B3 Transmission. //Am J Transplant. 2015;15(2):555-559.
Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab. Transfusion. 2015.
Liver fluke-infested graft used for living-donor liver transplantation: case report and review of the literature. Transpl Infect Dis. 2015;17(6).
Low-risk transfusion-related acute lung injury donor strategies and the impact on the onset of transfusion-related acute lung injury: a meta-analysis. //Transfusion. 2015;55(1):164-175.
Nine-year follow-up in a child with chromosomal integration of human herpesvirus 6 transmitted from an unrelated donor through the Japan Marrow Donor Program. //Transpl Infect Dis. 2015;17(1):160-161.
The Notify Library: educational database for professionals working whit Medical Products of Human Origin. Transfusion today. 2015;102(March):16-17.